Ligand Pharmaceuticals (LGND) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Ligand Pharmaceuticals (LGND) over the last 13 years, with Q4 2022 value amounting to $17.0 million.
- Ligand Pharmaceuticals' Shares Outstanding rose 109.74% to $17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $17.0 million, marking a year-over-year increase of 109.74%. This contributed to the annual value of $17.0 million for FY2022, which is 109.74% up from last year.
- Latest data reveals that Ligand Pharmaceuticals reported Shares Outstanding of $17.0 million as of Q4 2022, which was up 109.74% from $16.9 million recorded in Q1 2022.
- In the past 5 years, Ligand Pharmaceuticals' Shares Outstanding registered a high of $21.3 million during Q1 2018, and its lowest value of $16.0 million during Q1 2020.
- For the 5-year period, Ligand Pharmaceuticals' Shares Outstanding averaged around $17.9 million, with its median value being $16.8 million (2019).
- In the last 5 years, Ligand Pharmaceuticals' Shares Outstanding tumbled by 1898.3% in 2019 and then skyrocketed by 427.24% in 2021.
- Ligand Pharmaceuticals' Shares Outstanding (Quarter) stood at $20.8 million in 2018, then decreased by 18.98% to $16.8 million in 2019, then fell by 4.42% to $16.1 million in 2020, then rose by 4.27% to $16.8 million in 2021, then grew by 1.1% to $17.0 million in 2022.
- Its last three reported values are $17.0 million in Q4 2022, $16.9 million for Q1 2022, and $16.8 million during Q4 2021.